Eighteen years ago, PT Ferron Par Pharmaceuticals shipped its first pharmaceutical products from Indonesia to the European market. On Thursday (June 4, 2026), the company marked another significant milestone with the official dispatch of its 150th export container from Ferron’s manufacturing facility in Cikarang, West Java. The ceremony was officiated by the Head of the Indonesian Food and Drug Authority (BPOM RI), Prof. Taruna Ikrar, MD, M.Biomed., Ph.D. The 150-container mi

PT Ferron Par Pharmaceuticals, in collaboration with the Indonesian Society of Endocrinology (PERKENI), held the Cardio-Vascular Metabolic (CVM) Summit titled “1st Ferron CVM Summit.” During the event, Ferron launched its latest anti-diabetes product, Fliptin. The event was attended by Dexa Group CEO, Mr. Ferry Soetikno; Dexa Group President Commissioner, Mrs. Gracianti Soetikno; Molecular Pharmacologist and also Dexa Group’s Business Development and Scientific Affairs Direct

Dexa Group is committed to supporting government programs to increase the use of domestic pharmaceutical products to achieve health resilience and independence. For this reason, the Ministry of Health presented three awards to Dexa Group at the National Forum for Down Streaming and Increasing the Use of Domestic Pharmaceutical Products in Jakarta Tuesday (16/5/2023). The awards received by Dexa Group are the Pharmaceutical Industry Award for Producing Chemical Raw Materials,

Indonesia’s Ministry of Industry accelerates seven industrial sectors, including pharmaceuticals, in implementing the Making Indonesia 4.0 roadmap to make Indonesia the top 10 big countries with the most robust economy globally by 2030. In line with this effort, as Indonesia’s leading international pharmaceutical company, Dexa Group has implemented industry 4.0 in its production process to distribution. Director of Corporate Affairs Dexa Group, Mr. Krestijanto Pandji, in his

Dexa Group, as a national pharmaceutical company, is committed to meeting the quality of Indonesian natural raw materials as the content of Indonesian Indigenous Modern Medicines, beginning with cultivation, harvesting, and post-harvest processes and continuing through the manufacturing process by Good Traditional Medicine Manufacturing standards (CPOTB). This is necessary to preserve the ecosystem’s consistency for developing natural raw materials and applying phytopharmaceu

The economic crisis that hit Sri Lanka caused a lack of supplies of medicines in the country and encouraged the concern of pharmaceutical companies in Indonesia to donate medicines and medical devices, including Dexa Group. The World Health Organization authorities submitted the request to the Indonesian government through the Indonesian Ministry of Foreign Affairs and the Ministry of Health of the Republic of Indonesia. The symbolic donation was held at the Soekarno-Hatta Ai

Dexa Group is one of the pharmaceutical companies that take part in Business Matching activities organized by the Ministry of Industry to maximize the purchase of domestic products. The event, which took place on the 22nd until 24th of March 2022 in Nusa Dua, Bali, continued the Bangga Buatan Indonesia (BBI) movement, which aims to increase the use of domestic products. Mr. Agus Gumiwang Kartasasmita, Minister of Industry, stated that his party aims to achieve an 80 percent a

The Ministry of Industry continues to improve the competitiveness of the national industry through the transformation towards industry 4.0. In this regard, as a leading international pharmaceutical company in Indonesia, Dexa Group has implemented Industry 4.0 in the production process to distribution. President Director of PT Ferron Par Pharmaceuticals, Mr. Krestijanto Pandji, stated that companies that are able to survive in the industrial era 4.0 are those that are able to

Dexa Group through PT. Ferron Par Pharmaceuticals received the Annual Corporate Social Responsibility award from the West Java Provincial Government on November 18, 2019. This award was given for the PT. Ferron Par Pharmaceuticals’ consistency in implementing social and environmental responsibility programs in the West Java area via Dharma Dexa activities. The award ceremony was held in conjunction with the Inauguration of West Java CSR Projects which had been carried out thr

PT Ferron Par Pharmaceuticals won the Primaniyarta Award 2019 in the Global Brand Developer category. The award was given by the Vice President of the Republic of Indonesia, H. M. Jusuf Kalla to Dexa Group Chairman, Ferry Soetikno at the opening ceremony of Trade Expo Indonesia, at ICE Bumi Serpong Damai Banten on Wednesday, October 16, 2019. Primaniyarta Award is the greatest reward given by the Government of the Republic of Indonesia to the most successful Indonesian export